2001 Quarterly Earnings Reports
Genomics Sector Companies
Updated 4/23/03
Current publicly reported financial results (in $millions) for genomics-based companies. Please note that all figures may reflect non-recurring charges, credits, gains or losses. Company fiscal years may not run according to the calendar year. Earnings will be updated as Network Science receives the data.
| Q1 | Q2 | Q3 | Q4 | YTD | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | |
| Affymetrix (AFFX) | $54.89 | ($10.76) | $49.55 | ($9.11) | $55.37 | ($4.80) | $55.20 | ($8.45) | $194.90 | ($33.12) |
| Celera Genomics Corp (CRA) | $23.40 | ($29.10) | $27.40 | ($101.70) | $27.30 | ($15.60) | $35.00 | ($117.90) | $113.10 | ($264.30) |
| CuraGen (CRGN) | $5.66 | ($5.35) | $6.24 | ($10.28) | $6.08 | ($11.12) | $5.50 | ($16.20) | $23.48 | ($42.95) |
| Ciphergen Biosystems (CIPH) | $2.68 | ($5.98) | $3.66 | ($5.81) | $5.40 | ($6.90) | $7.30 | ($7.10) | $19.04 | ($25.79) |
| DeltaGen | $2.45 | ($7.07) | $2.74 | ($11.86) | $2.27 | ($14.63) | $2.46 | ($14.89) | $9.92 | ($48.45) |
| GeneLabs Technologies (GNLB) | $1.50 | ($2.86) | $1.10 | ($3.68) | $1.10 | ($3.00) | $1.10 | ($3.40) | $4.80 | ($12.94) |
| GeneLogic (GLGC) | $8.21 | ($10.61) | $9.60 | ($9.36) | $11.50 | ($7.24) | $13.96 | ($5.97) | $43.27 | ($33.18) |
| Genome Therapeutics (GENE) | $8.09 | ($0.07) | $11.39 | $2.10 | $7.38 | ($4.18) | $8.88 | ($7.94) | $35.74 | ($10.09) |
| Human Genome Sciences (HGSI) | $5.27 | ($13.01) | $5.30 | ($24.02) | $1.64 | ($24.88) | $0.64 | ($55.24) | $12.85 | ($117.15) |
| Incyte (INCY) | $51.10 | ($10.30) | $56.05 | ($9.89) | $57.32 | ($17.83) | $54.77 | ($145.20) | $219.24 | ($183.22) |
| Invitrogen (IVGN) | $160.70 | ($39.57) | $159.33 | ($35.10) | $156.00 | ($37.40) | $153.30 | ($35.60) | $629.33 | ($147.67) |
| Lexicon Genetics (LEXG) | $3.31 | ($8.01) | $3.50 | ($9.94) | $13.49 | ($6.22) | $10.27 | ($11.06) | $30.57 | ($35.23) |
| Millennium Pharmaceuticals (MLNM) | $50.36 | ($51.13) | $59.07 | ($46.73) | $82.17 | ($25.23) | $54.61 | ($66.97) | $246.21 | ($190.06) |
| Myriad Genetics (MYGN) | $11.57 | ($1.73) | $10.82 | ($2.19) | $13.19 | ($1.19) | $13.48 | ($2.46) | $49.06 | ($7.57) |
| Paradigm Genetics (PDGM) | $5.45 | ($4.01) | $6.06 | ($4.30) | $6.25 | ($4.06) | $6.70 | ($3.70) | $24.46 | ($16.07) |
| Targeted Genetics (TGEN) | $3.81 | ($6.24) | $4.30 | ($5.86) | $5.54 | ($6.99) | $5.20 | ($8.07) | $18.84 | ($27.16) |
| Visible Genetics (VGIN) | $3.60 | ($8.58) | $3.93 | ($9.37) | $2.89 | ($11.69) | $3.19 | ($11.91) | $13.61 | ($41.55) |
| Vysis (VYSI) Acquired by Abbott 12/01 | $6.53 | $1.08 | $6.79 | $1.27 | $7.26 | $2.52 | $20.58 | $4.87 | ||
| Totals | $408.58 | ($213.29) | $426.83 | ($295.83) | $462.15 | ($200.44) | $431.56 | ($522.06) | $1,709.02 | ($1,231.61) |
